Skip to main content
Main Menu
  • Capabilities
    Back
    Capabilities
    • Assembly
    • Catheter Tubing Extrusion & Secondary Operations
    • Catheter Systems Design & Manufacturing
    • FreeWave™ Specialized Silicone Laser Technology
    • High Purity Specialty Closures
      Back
      High Purity Specialty Closures
      • Closure Assemblies
      • Liners
    • Custom Compounding
    • Custom Filtration
    • Medical Extrusion
    • Medical Molding
    • Prototyping and Tooling
    • Product Co-Development
  • Materials
    Back
    Materials
    • Fluoropolymers
      Back
      Fluoropolymers
      • Fluoropolymers 101
      • Fluoropolymers 201
    • Other Materials
    • Silicone
      Back
      Silicone
      • Silicone 101
    • Thermoplastics
      Back
      Thermoplastics
      • Thermoplastics 101
      • PEEK page
      • Thermoplastics 201
  • Markets
    Back
    Markets
    • Cardiology
    • Diabetic Care
    • Drug Delivery
    • Endoscopy
    • Nephrology
    • Ophthalmology
    • Other Medical Markets
    • Surgery
  • Resources
    Back
    Resources
    • Schedule a Lunch and Learn
    • Technical Data and Literature
    • White Papers
      Back
      White Papers
      • Effect of Sterilization on the Mechanical Properties
      • Extruded Silicone Tubing with Optimized Precision for medical device manufacturers
      • Flow Rate Stability of Medical Peristaltic Pump Tubing Materials
      • Liquid Silicone Rubber Injection Molding
      • Low Coefficient of Friction Materials: Tygon® LCF Offers the Ideal Combination
      • The Impact of Gamma and Autoclave Sterilization on Silicone Tubing
      • Two-Shot Silicone-Thermoplastic Medical Molding
    • Quality and Regulatory
      Back
      Quality and Regulatory
      • Medical Product Disclaimer
      • ISO Certifications
    • FAQs
    • Videos
  • About Us
    Back
    About Us
    • Blog
    • Case Study
    • Events
    • News
    • Webinar
  • Contact Us
world SAINT-GOBAIN
Logo Saint-Gobain Medical
  • Capabilities
    • Assembly
    • Catheter Tubing Extrusion & Secondary Operations
    • Catheter Systems Design & Manufacturing
    • FreeWave™ Specialized Silicone Laser Technology
    • High Purity Specialty Closures
      • Closure Assemblies
      • Liners
    • Custom Compounding
    • Custom Filtration
    • Medical Extrusion
    • Medical Molding
    • Prototyping and Tooling
    • Product Co-Development
  • Materials
    • Fluoropolymers
      • Fluoropolymers 101
      • Fluoropolymers 201
    • Other Materials
    • Silicone
      • Silicone 101
    • Thermoplastics
      • Thermoplastics 101
      • PEEK page
      • Thermoplastics 201
  • Markets
    • Cardiology
    • Diabetic Care
    • Drug Delivery
    • Endoscopy
    • Nephrology
    • Ophthalmology
    • Other Medical Markets
    • Surgery
  • Resources
    • Schedule a Lunch and Learn
    • Technical Data and Literature
    • White Papers
      • Liquid Silicone Rubber Injection Molding
      • Effect of Sterilization on the Mechanical Properties
      • Two-Shot Silicone-Thermoplastic Medical Molding
      • Extruded Silicone Tubing with Optimized Precision for medical device manufacturers
      • Low Coefficient of Friction Materials: Tygon® LCF Offers the Ideal Combination
      • The Impact of Gamma and Autoclave Sterilization on Silicone Tubing
      • Flow Rate Stability of Medical Peristaltic Pump Tubing Materials
    • Quality and Regulatory
      • Medical Product Disclaimer
      • ISO Certifications
    • FAQs
    • Videos
  • About Us
    • Blog
    • Case Study
    • Events
    • News
    • Webinar
  • Contact Us

 

You are here

  1. Home
  2. About Us
  3. Blog
  4. EU MDR – What is it and why is it necessary?

EU MDR – What is it and why is it necessary?

March 15th, 2021

Author: Dorothy Wilkerson – Regulatory Affairs Manager, Saint-Gobain Medical Components

The new European Union Medical Device Regulation (EU MDR (EU) No. 2017/745) and In Vitro Diagnostic Regulation (IVDR) present the first major changes to the EU medical device regulatory environment in over 20 years. The two regulations replace three existing Medical Device Directives (MDD).

These regulations go into effect May 26, 2021 for MDR and May 26, 2022 for IVDR and are applicable for all EU member countries.

What is it? The EU MDR is the set of regulations that governs the production and distribution of medical devices in Europe. Compliance with this regulation is mandatory for medical device companies (legal manufacturers) that want to market or sell their products in the EEA (European Economic Area). There are 27 EU member countries. The EU MDR in its entirety is applicable to finished medical devices.

Why is it necessary? Some of the drivers for this change were due to:

  • Medical Device Safety scandals in the EU
  • Varied interpretations of the laws among EU member states
  • ISO 13485 could not meet all of the needs for this regulation
  • Limited means to monitor medical device regulations

The above factors are some of the reasons that the MDD is being replaced with the new regulation to ensure compliance with standardized medical device regulations throughout Europe. The structure of the EU MDR contains 10 Chapters, 123 Articles and 17 Annexes which includes 175 pages making it a comprehensive document that covers all aspects of the regulation. The EU MDR regulations are intended to improve the safety and performance of medical devices in Europe and intends to provide a high level of protection for the health of patients and users of these medical devices.

How to be compliant? A summary of activities that must be met in order to be compliant and obtain a CE mark for devices is illustrated below. A brief summary of what technical documentation comprises of is also shown.

What are UDI requirements? One of the requirements of the EU MDR is that all medical devices will now need to be assigned a unique device identification (UDI) code.

Devices which fall under Class III and IIa/b products will need to have their UDI recorded, indexed, and registered on a central EU database called EUDAMED – the European Database for Medical Devices. Manufacturers of these products will be responsible for sharing product data according to the Annex VI Part B of the regulation.

Manufacturers of Class I products will also be required to collect and save product data but will only need to share the information upon request. The EU MDR obligates medical device manufacturers to invest in the software and technology to allow for fast and accurate traceability coding to products and packaging at the individual item level. Noncompliance with these procedures may mean that the medical devices will be pulled off of the market and will no longer be for sale in the EU member states. Manufacturers will be required to audit and check their products on a regular basis to ensure compliance. The illustration below shows the general process for obtaining a UDI.

Who does the EU MDR affect? The EU MDR includes all items sold within the EU. However, all manufacturers that wish to sell their products in the EU need to ensure that they satisfy the EU MDR requirements or the sale of their products will be prohibited; this includes other countries such as the United States selling products to Europe.

How does the EU MDR affect Saint-Gobain? Saint-Gobain is aware of the application and enforcement of the EU MDR come May 2021. Saint-Gobain is not currently a legal manufacturer of any finished medical device, rather Saint-Gobain is a supplier to our customers who are the legal manufacturers. While the MDR requirements are not directly applicable to Saint-Gobain, we are aware of the requirements that our customers must adhere to and are willing to support and provide compliance information where applicable specific to the components and products that Saint-Gobain does provide.

Dorothy Wilkerson - Regulatory Affairs Manager - Saint-Gobain Life Sciences

Dorothy Wilkerson obtained her Bachelor’s and Master’s degrees both in Biomedical Engineering.  Dorothy has over 15 years of experience at several medical device companies in engineering, quality, and regulatory-related roles.  Dorothy works closely with the Saint-Gobain Life Sciences Medical Components commercial team in the business development initiatives, business reviews, and continued execution of Saint-Gobain’s medical strategy. 

About Saint-Gobain

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in so many industrial applications.

 

Saint-Gobain Performance Plastics' group of businesses gather solutions to save energy, provide protection, improve comfort and sustain the environment for a variety of markets.

MENU

Capabilities
Materials
Markets
Resources
FAQs
About Us
Contact Us
Schedule a Lunch and Learn
Legal
CATSCA

 

 

 

FOLLOW US

 

 CONTACT US

Saint-Gobain’s medical products are distributed exclusively to medical device manufacturers for use in the manufacture, assembly or distribution of their medical devices. Saint-Gobain cannot authorize the sale of its medical products directly to device user facilities (e.g. hospitals, surgery centers, nursing home, clinics, etc.), nor directly to end users (e.g. patients, patients’ caregiver, prescribing physician, nurse, pharmacist, etc.), including distributors serving device user facilities and end users directly. In accordance with every jurisdiction globally, Saint-Gobain’s customers are responsible for determining that any medical device they manufacture and market that incorporates a Saint-Gobain’s medical product, is compliant with each country-specific medical device regulations and has received proper country-specific clearance, certification or registration authorizing the sale of this medical device.


Saint-Gobain’s medical products offer covers:
- Medical Components [21 CFR 820.3(c)], intended for processing or use in the manufacture or assembly of medical devices before the finished medical device is packaged/labeled; Medical Components are intended to be included as part of the finished, packaged, and labeled device [21CFR820.3(c)].
- Finished Devices [21CFR820.3(l)] made on behalf of medical device manufacturers [21 CFR 807.20(a)(2)] under contract-manufacturing agreement. In accordance with the United States’ jurisdiction, Saint-Gobain complies with the FDA’s requirements for contract manufacturers of finished devices.

© Copyright Saint-Gobain 2019. All rights reserved.